VanEck JP Morgan EM Local Currency Bond ETF vs Herbalife Nutrition Ltd — how do they compare? VanEck JP Morgan EM Local Currency Bond ETF trades at $24.83 (market cap $4.93B), while Herbalife Nutrition Ltd trades at $12.89 (market cap $1.34B). The key difference: VanEck JP Morgan EM Local Currency Bond ETF is far larger — about 3.7× Herbalife Nutrition Ltd's market cap, and Herbalife Nutrition Ltd is trading nearer its 52-week high, VanEck JP Morgan EM Local Currency Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck JP Morgan EM Local Currency Bond ETF for 38 Days and Herbalife Nutrition Ltd for 43 Days on average.
| EMLC | HLF | |
|---|---|---|
Market Cap | $4.93B | $1.34B |
Volume | 2,843,860 | 1,589,457 |
Sector | Fixed Income | Consumer Staples |
52-Week High | $26.59 | $19.96 |
52-Week Low | $24.53 | $7.75 |
Typical Hold Time | 38 Days | 43 Days |
Enterprise Value | — | $3.18B |
Signals from Pluang's Aura AI — not financial advice
EMLC trades at $24.77, down 0.24% on the day and hitting a new 52-week low. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. The ETF faces headwinds from dollar strength and Fed rate hike expectations, though emerging market bonds have shown relative outperformance in 2026. Recent dividends of $0.14 and $0.13 were declared for October and August 2026 respectively.
The outlook remains cautious as dollar strength and rising global bond yields create challenges for emerging market local currency debt. While diversification benefits exist, near-term performance depends on currency dynamics and Federal Reserve policy direction. Key risks include currency volatility and global interest rate movements affecting bond valuations.
Herbalife (HLF) trades at $12.86, up 1.62% on the day, with a bullish technical signal and a consensus analyst price target of $19.00 implying significant upside. The company reported Q2 2026 EPS of $0.51, missing expectations, but reaffirmed full-year 2026 guidance. Financials show a net income margin of 3.16% for 2025, with a low P/E of 8.22 and P/S of 0.26, suggesting potential undervaluation. Recent news includes a $250 million share repurchase authorization and a planned CEO transition effective October 31, 2026.
The outlook for HLF is cautiously optimistic, with valuation metrics and analyst sentiment supporting a bullish case, but risks include recent earnings misses, high debt levels, and ongoing leadership changes. The stock presents a value opportunity if the company can execute on its growth and margin expansion plans while managing its leverage.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →